首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Increased proportion of perforin-expressing CD8+T-cells indicates control of herpesvirus reactivation in children after stem cell transplantation
【24h】

Increased proportion of perforin-expressing CD8+T-cells indicates control of herpesvirus reactivation in children after stem cell transplantation

机译:表达穿孔素的CD8 + T细胞比例增加表明干细胞移植后儿童疱疹病毒再激活得到控制

获取原文
获取原文并翻译 | 示例
           

摘要

Hematopoietic stem cell transplantation (HSCT) is frequently complicated by viral reactivations. Early diagnosis of viral reactivations and preemptive therapy relies on frequent viralload monitoring. An easy marker of effective cytotoxicity in lymphopenia is lacking and therefore we studied perforin-expression in CD8+. T-cells in children following HSCT. Prospectively, we weekly monitored viral loads and perforin-expression of CD8+. T-cells in whole blood by FACS, until 4. months after HSCT in children. 27 patients were included (median age 4,3, range 0.3-20,1. years) of whom 19 developed viral reactivations. These patients showed higher percentages of perforin-expressing CD8+. T-cells (17,2%, range 0-63%) than those without (6,8%; range 0-16%) (p. =. 0.001). The increased percentage of perforin-expressing CD8+. T-cells coincided with a decrease in viral load with a median interval between maximum viral load and maximum level of perforin-expression of 0,4. weeks (range 0.1-7.1). We conclude that perforin-expression in CD8. +. T-cells may be a marker for effective antiviral T-cell reconstitution early after HSCT in children.
机译:造血干细胞移植(HSCT)通常会因病毒激活而复杂化。病毒再激活和抢先治疗的早期诊断依赖于频繁的病毒载量监测。缺乏有效的淋巴细胞减少症有效细胞毒性标志物,因此我们研究了CD8 +中穿孔素的表达。 HSCT后儿童的T细胞。前瞻性地,我们每周监测病毒载量和CD8 +的穿孔素表达。儿童通过FACS进行全血T细胞检查,直到儿童进行HSCT后4.个月。纳入27例患者(中位年龄为4,3,范围0.3-20,1。岁),其中19例发生了病毒再激活。这些患者表现出较高的表达穿孔素的CD8 +百分比。 T细胞(17.2%,范围0-63%)比没有T细胞(6.8%;范围0-16%)(p。= 0.001)。表达穿孔素的CD8 +百分比增加。 T细胞与病毒载量减少同时出现,最大病毒载量与穿孔素表达的最大水平之间的中值间隔为0.4。周(范围0.1-7.1)。我们得出结论,CD8中穿孔素表达。 +。 T细胞可能是儿童HSCT后早期有效抗病毒T细胞重建的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号